Project Details
Description
PROVIDE-HF: Patient Reported Outcomes inVestigation following Initiation of Drug therapy with Entresto (Sacubitril/Valsartan) in Heart Failure
| Status | Finished |
|---|---|
| Effective start/end date | 1/12/18 → 12/31/19 |
Funding
- UNIVERSITY OF KANSAS MEDICAL CENTER
- NOVARTIS PHARMACEUTICALS CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.